Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India

Background: Hemolytic uremic syndrome (HUS) is a common cause of community acquired acute kidney injury (AKI) in childhood. Methodology: This descriptive study was conducted on 24 children from May 2019 to September 2020 at the Institute of Child Health and Hospital for Children, Chennai. Results: A...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinushya Selvam, H Syed Mohammed, Lakshmi Velmurugan, X Joshua Rajan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-06-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jpbs.jpbs_581_25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849420958988763136
author Vinushya Selvam
H Syed Mohammed
Lakshmi Velmurugan
X Joshua Rajan
author_facet Vinushya Selvam
H Syed Mohammed
Lakshmi Velmurugan
X Joshua Rajan
author_sort Vinushya Selvam
collection DOAJ
description Background: Hemolytic uremic syndrome (HUS) is a common cause of community acquired acute kidney injury (AKI) in childhood. Methodology: This descriptive study was conducted on 24 children from May 2019 to September 2020 at the Institute of Child Health and Hospital for Children, Chennai. Results: Among the study population, 62.5% of children had atypical hemolytic uremic syndrome (HUS) and 37.5% had typical HUS. The prevalence of HUS was equal between girls and boys in the study population. The mortality rate was higher in girls compared to boys. The progression to chronic kidney disease (CKD) was also more in girls. Clinical findings that were statistically significant concerning the overall outcome of this study were hypertension, acidotic breathing, and encephalopathy. The mean hemoglobin level is 5.8 g/dL and the association of hemoglobin with outcome was not statistically significant. Mortality was high in extremes of ages. Conclusion: High lactate dehydrogenase (LDH) was associated with poor outcomes whereas normal C3 and early hematology resolution were associated with better outcomes.
format Article
id doaj-art-9e10b48d5b744fb79aa8e9aa054fa51e
institution Kabale University
issn 0976-4879
0975-7406
language English
publishDate 2025-06-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj-art-9e10b48d5b744fb79aa8e9aa054fa51e2025-08-20T03:31:35ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0976-48790975-74062025-06-0117Suppl 2S1865S186710.4103/jpbs.jpbs_581_25Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South IndiaVinushya SelvamH Syed MohammedLakshmi VelmuruganX Joshua RajanBackground: Hemolytic uremic syndrome (HUS) is a common cause of community acquired acute kidney injury (AKI) in childhood. Methodology: This descriptive study was conducted on 24 children from May 2019 to September 2020 at the Institute of Child Health and Hospital for Children, Chennai. Results: Among the study population, 62.5% of children had atypical hemolytic uremic syndrome (HUS) and 37.5% had typical HUS. The prevalence of HUS was equal between girls and boys in the study population. The mortality rate was higher in girls compared to boys. The progression to chronic kidney disease (CKD) was also more in girls. Clinical findings that were statistically significant concerning the overall outcome of this study were hypertension, acidotic breathing, and encephalopathy. The mean hemoglobin level is 5.8 g/dL and the association of hemoglobin with outcome was not statistically significant. Mortality was high in extremes of ages. Conclusion: High lactate dehydrogenase (LDH) was associated with poor outcomes whereas normal C3 and early hematology resolution were associated with better outcomes.https://journals.lww.com/10.4103/jpbs.jpbs_581_25childrenhemolytic uremic syndromeimmunohematological
spellingShingle Vinushya Selvam
H Syed Mohammed
Lakshmi Velmurugan
X Joshua Rajan
Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
Journal of Pharmacy and Bioallied Sciences
children
hemolytic uremic syndrome
immunohematological
title Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
title_full Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
title_fullStr Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
title_full_unstemmed Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
title_short Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
title_sort clinical epidemiological and immunohematological profile of hemolytic uremic syndrome in children between 6 months and 12 years at a tertiary care center in south india
topic children
hemolytic uremic syndrome
immunohematological
url https://journals.lww.com/10.4103/jpbs.jpbs_581_25
work_keys_str_mv AT vinushyaselvam clinicalepidemiologicalandimmunohematologicalprofileofhemolyticuremicsyndromeinchildrenbetween6monthsand12yearsatatertiarycarecenterinsouthindia
AT hsyedmohammed clinicalepidemiologicalandimmunohematologicalprofileofhemolyticuremicsyndromeinchildrenbetween6monthsand12yearsatatertiarycarecenterinsouthindia
AT lakshmivelmurugan clinicalepidemiologicalandimmunohematologicalprofileofhemolyticuremicsyndromeinchildrenbetween6monthsand12yearsatatertiarycarecenterinsouthindia
AT xjoshuarajan clinicalepidemiologicalandimmunohematologicalprofileofhemolyticuremicsyndromeinchildrenbetween6monthsand12yearsatatertiarycarecenterinsouthindia